10th Edition of World Congress on Infectious Diseases
June 25-27, 2026 | Barcelona, Spain
Hib Disease
Hib disease, short for Haemophilus influenzae type b disease, is a serious bacterial infection caused by the bacterium Haemophilus influenzae type b. This pathogen primarily affects young children, particularly those under the age of five, and can lead to severe complications such as pneumonia, meningitis, and epiglottitis. Hib disease was once a leading cause of bacterial meningitis and other invasive infections in young children before the introduction of the Hib vaccine. However, in regions where vaccination rates are low, Hib disease remains a significant public health concern. Timely immunization with the Hib vaccine is essential for preventing this potentially life-threatening illness and protecting vulnerable populations, highlighting the importance of vaccination efforts in maintaining community health and safety.
Francis J Castellino
University of Notre Dame, United States
Ranjan Ramasamy
ID-FISH Technology, United States
Yazdan Mirzanejad
University of British Columbia, Canada
Alexis Torres Rodriguez
NewYork-Presbyterian Queens Hospital, United States
Sasha Leibholz
New York Presbyterian Columbia/Cornell, United States
Hana Raza
Mclaren Oakland Hospital, United States
Terri Menser
Mayo Clinic, United StatesSubmit your abstract Today
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation